FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,460,788 | +135.1% | 1,004,682 | +74.8% | 0.00% | +100.0% |
| Q2 2023 | $1,897,028 | +107137.3% | 574,857 | -7.4% | 0.00% | 0.0% |
| Q1 2023 | $1,769 | -99.6% | 620,559 | +664.3% | 0.00% | – |
| Q2 2022 | $398,000 | -51.9% | 81,197 | +132.0% | 0.00% | – |
| Q1 2022 | $828,000 | -37.2% | 35,000 | -53.0% | 0.00% | -100.0% |
| Q4 2021 | $1,318,000 | -53.1% | 74,475 | -25.3% | 0.00% | -50.0% |
| Q3 2021 | $2,813,000 | -57.1% | 99,707 | -84.1% | 0.00% | -50.0% |
| Q2 2021 | $6,557,000 | -6.5% | 625,635 | +5.1% | 0.00% | -20.0% |
| Q1 2021 | $7,010,000 | +1440.7% | 595,061 | +1431.2% | 0.01% | – |
| Q4 2020 | $455,000 | -47.0% | 38,862 | -17.2% | 0.00% | -100.0% |
| Q2 2020 | $859,000 | -61.1% | 46,947 | -74.6% | 0.00% | -80.0% |
| Q1 2020 | $2,209,000 | +47.2% | 185,019 | +105.2% | 0.01% | +150.0% |
| Q4 2019 | $1,501,000 | -27.3% | 90,181 | -71.0% | 0.00% | -33.3% |
| Q3 2019 | $2,065,000 | – | 311,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |